13F

Stock

Coherus Oncology, Inc.

CHRS · held by 4 managers

Reported value

$222.6K

Holders

4

+0 new · −0 exited

Holders’ est. mark

−$17.8K

Price effect on 3 books still in the name

Largest holder

$217.7K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC297.7K$217.7K−$17.5KAdded$31.3K
Medallion Wealth Advisors, LLC6K$4.56K−$275Cut−$275
Essential Partners LLC464$339Held
Clark Wealth Partners23$17−$2Cut−$2

Positions as of Q2 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.